Since we showed that 14 kDa hGH requires PAI-1 to mediate its antitumoral and antiangiogenic effects, the levels of PAI-1 expressed by tumor cells or in the tumor microenvironment will be a determinant factor for the efficiency of 14 kDa hGH. This evidence concerns the gene GH1 and neoplasm.